from Viromed Medical AG (isin : DE000A3MQR65)
EQS-Adhoc: Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Alliance
Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
28-Nov-2025 / 17:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
Rellingen, November 28, 2025 – Viromed Medical AG, a specialist in medical technologies, and HELLMUT RUCK GmbH, a leading provider of podiatry, foot care, and cosmetic solutions, announce the conclusion of an exclusive partnership for Europe, including Switzerland. As part of this cooperation, RUCK will exclusively distribute innovative plasma devices as an OEM product. The collaboration combines the technological expertise of Viromed with the strong market position and sales experience of RUCK. The aim is to provide professional users in podiatry, foot care, cosmetics, and medicine with a forward-looking solution for hygienic and skin-friendly treatments.
Notifying person:
Uwe Perbandt, CEO Viromed Medical AG
Contact Viromed:
E-Mail: kontakt@viromed-medical.de
End of Inside Information
28-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
| Language: | English |
| Company: | Viromed Medical AG |
| Hauptstraße 105 | |
| 25462 Rellingen | |
| Germany | |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Tradegate Exchange |
| EQS News ID: | 2237640 |
| End of Announcement | EQS News Service |
2237640 28-Nov-2025 CET/CEST